Rozerem and Bursitis - a phase IV clinical study of FDA data

Summary:

Bursitis is reported as a side effect among people who take Rozerem (ramelteon), especially for people who are female, 50-59 old, also take Femara, and have Breast cancer.

The phase IV clinical study analyzes which people have Bursitis when taking Rozerem. It is created by eHealthMe based on reports of 7,343 people who have side effects when taking Rozerem from the FDA, and is updated regularly.

What is Rozerem?

Rozerem has active ingredients of ramelteon. It is often used in insomnia. eHealthMe is studying from 7,539 Rozerem users. Check the latest studies of Rozerem.

What is Bursitis?

Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder) is found to be associated with 1,168 drugs and 1,054 conditions by eHealthMe. Check the latest studies of Bursitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

7,343 people reported to have side effects when taking Rozerem.
Among them, 25 people (0.34%) have Bursitis.

Among these 25 people:

What is the gender of people who have Bursitis when taking Rozerem? *

female: 88 %
male: 12 %

What is the age of people who have Bursitis when taking Rozerem? *

What are other drugs people take besides Rozerem? *

What are other side effects people have besides Bursitis? *

Nausea And Vomiting: 20 people, 80.00%
Pain In Extremity: 20 people, 80.00%
Anaemia (lack of blood): 17 people, 68.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 17 people, 68.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 16 people, 64.00%
Bone Density Decreased: 16 people, 64.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 64.00%
Fall: 14 people, 56.00%
Nausea (feeling of having an urge to vomit): 14 people, 56.00%
High Blood Pressure: 14 people, 56.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 28.00%
Osteopenia (a condition where bone mineral density is lower than normal): 7 people, 28.00%
Hypersensitivity: 7 people, 28.00%
Headache (pain in head): 7 people, 28.00%
Breast Cancer: 7 people, 28.00%
Menopause (end of monthly cycles in women): 6 people, 24.00%
Depression: 6 people, 24.00%
Metastases To Bone (cancer spreads to bone): 1 person, 4.00%
Hallucinations (sensations that appear real but are created by your mind): 1 person, 4.00%
Dementia (madness): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Rozerem and have Bursitis?

- Check whether Bursitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rozerem:

Rozerem (7,539 reports)

Bursitis treatments and more:

Bursitis (18,537 reports)

Browse all side effects of Rozerem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bursitis:

Bursitis (1,168 drugs)

Browse all the conditions that are associated with Bursitis:

Bursitis (1,054 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramelteon (the active ingredients of Rozerem) and Rozerem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.